amlitelimab IV (SAR445229) - Sanofi
Ebglyss (lebrikizumab-lbkz) - Eli Lilly
rademikibart (CBP-201) - Suzhou Connect Biopharma
rezpegaldesleukin (NKTR-358) - Nektar Therapeutics
Adbry (tralokinumab-ldrm) - LEO Pharma, AstraZeneca
rocatinlimab (AMG 451) - Kyowa Kirin
Dupixent (dupilumab) - Sanofi, Regeneron
zumilokibart (APG777) - Apogee Therap
telazorlimab (ISB 830) - BioCryst Pharmaceuticals
http://www.ncbi.nlm.nih.gov/pubmed/41884322
 
Arya Babul; Devina Mehta; Momina Hussain; Najib Babul; Yssra Soliman
 
Mar 26, 2026
 
Prev Next